Europe Pneumococcal Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022


Report ID : RNR-195661 Category : Medical Devices Published Date : 8/15/2017
Publisher : GlobalInfo Research Pages : 115 Format : PDF
"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control)."

Scope of the Report:
This report focuses on the Pneumococcal Vaccine in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
    Pfizer
    GSK
    MSD
    Sanofipasteur
    CDIBP

Market Segment by Countries, covering
    Germany
    UK
    France
    Russia
    Italy

Market Segment by Type, covers
    PPSV 23
    PCV 7/13
    PCV 10

Market Segment by Applications, can be divided into
    Child
    Adult

There are 17 Chapters to deeply display the Europe Pneumococcal Vaccine market.

Chapter 1, to describe Pneumococcal Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Pneumococcal Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Pneumococcal Vaccine, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;

Chapter 12, Pneumococcal Vaccine market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Pneumococcal Vaccine Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
    1.1 Pneumococcal Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 PPSV 23
        1.2.2 PCV 7/13
        1.2.3 PCV 10
    1.3 Market Analysis by Applications
        1.3.1 Child
        1.3.2 Adult
    1.4 Market Analysis by Countries
        1.4.1 Germany Status and Prospect (2012-2022)
        1.4.2 France Status and Prospect (2012-2022)
        1.4.3 UK Status and Prospect (2012-2022)
        1.4.4 Russia Status and Prospect (2012-2022)
        1.4.5 Italy Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Profile
        2.1.2 Pneumococcal Vaccine Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 Pfizer News
    2.2 GSK
        2.2.1 Profile
        2.2.2 Pneumococcal Vaccine Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 GSK News
    2.3 MSD
        2.3.1 Profile
        2.3.2 Pneumococcal Vaccine Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 MSD News
    2.4 Sanofipasteur
        2.4.1 Profile
        2.4.2 Pneumococcal Vaccine Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 Sanofipasteur News
    2.5 CDIBP
        2.5.1 Profile
        2.5.2 Pneumococcal Vaccine Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.5.4 Business Overview
        2.5.5 CDIBP News
3 Europe Pneumococcal Vaccine Market Competition, by Manufacturer
    3.1 Europe Pneumococcal Vaccine Sales and Market Share by Manufacturer (2016-2017)
    3.2 Europe Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Europe Pneumococcal Vaccine Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share
        3.4.2 Top 5 Pneumococcal Vaccine Manufacturer Market Share
    3.5 Market Competition Trend
4 Europe Pneumococcal Vaccine Market Analysis by Countries (2012-2017)
    4.1 Europe Pneumococcal Vaccine Sales Market Share by Countries (2012-2017)
    4.2 Europe Pneumococcal Vaccine Sales by Countries (2012-2017)
    4.3 Europe Pneumococcal Vaccine Revenue (Value) by Countries (2012-2017)
5 Europe Market Segmentation Pneumococcal Vaccine by Type
    5.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 Europe Pneumococcal Vaccine Sales and Market Share by Type (2012-2017)
        5.1.2 Europe Pneumococcal Vaccine Revenue and Market Share by Type (2012-2017)
    5.2 PPSV 23 Sales Growth and Price
        5.2.1 Europe PPSV 23 Sales Growth (2012-2017)
        5.2.2 Europe PPSV 23 Price (2012-2017)
    5.3 PCV 7/13 Sales Growth and Price
        5.3.1 Europe PCV 7/13 Sales Growth (2012-2017)
        5.3.2 Europe PCV 7/13 Price (2012-2017)
    5.4 PCV 10 Sales Growth and Price
        5.4.1 Europe PCV 10 Sales Growth (2012-2017)
        5.4.2 Europe PCV 10 Price (2012-2017)
6 Europe Market Segmentation Pneumococcal Vaccine by Application
    6.1 Europe Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
    6.2 Child Sales Growth (2012-2017)
    6.3 Adult Sales Growth (2012-2017)
7 Germany Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
    7.1 Germany Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
    7.2 Germany Pneumococcal Vaccine Sales and Market Share by Type (2012-2017)
    7.3 Germany Pneumococcal Vaccine Sales by Application (2012-2017)
    7.4 Germany Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
        7.4.1 Germany Pneumococcal Vaccine Sales and Market Share by Manufacturer (2016-2017)
        7.4.2 Germany Pneumococcal Vaccine Revenue and Market Share by Manufacturer
    7.5 Germany Pneumococcal Vaccine Export and Import (2012-2017)
8 UK Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
    8.1 UK Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
    8.2 UK Pneumococcal Vaccine Sales and Market Share by Type (2012-2017)
    8.3 UK Pneumococcal Vaccine Sales by Application (2012-2017)
    8.4 UK Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
        8.4.1 UK Pneumococcal Vaccine Sales and Market Share by Manufacturer
        8.4.2 UK Pneumococcal Vaccine Revenue and Market Share by Manufacturer
    8.5 UK Pneumococcal Vaccine Export and Import (2012-2017)
9 France Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
    9.1 France Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
    9.2 France Pneumococcal Vaccine Sales and Market Share by Type (2012-2017)
    9.3 France Pneumococcal Vaccine Sales by Application (2012-2017)
    9.4 France Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
        9.4.1 France Pneumococcal Vaccine Sales and Market Share by Manufacturer
        9.4.2 France Pneumococcal Vaccine Revenue and Market Share by Manufacturer
    9.5 France Pneumococcal Vaccine Export and Import (2012-2017)
10 Russia Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
    10.1 Russia Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
    10.2 Russia Pneumococcal Vaccine Sales and Market Share by Type
    10.3 Russia Pneumococcal Vaccine Sales by Application (2012-2017)
    10.4 Russia Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
        10.4.1 Russia Pneumococcal Vaccine Sales and Market Share by Manufacturer
        10.4.2 Russia Pneumococcal Vaccine Revenue and Market Share by Manufacturer
    10.5 Russia Pneumococcal Vaccine Export and Import (2012-2017)
11 Italy Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
    11.1 Italy Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
    11.2 Italy Pneumococcal Vaccine Sales and Market Share by Type
    11.3 Italy Pneumococcal Vaccine Sales by Application (2012-2017)
    11.4 Italy Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
        11.4.1 Italy Pneumococcal Vaccine Sales and Market Share by Manufacturer
        11.4.2 Italy Pneumococcal Vaccine Revenue and Market Share by Manufacturer
    11.5 Italy Pneumococcal Vaccine Export and Import (2012-2017)
12 Pneumococcal Vaccine Market Forecast (2017-2022)
    12.1 Europe Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022)
    12.2 Pneumococcal Vaccine Market Forecast by Countries (2017-2022)
        12.2.1 Germany Pneumococcal Vaccine Sales Forecast (2017-2022)
        12.2.2 UK Pneumococcal Vaccine Sales Forecast (2017-2022)
        12.2.3 France Pneumococcal Vaccine Sales Forecast (2017-2022)
        12.2.4 Russia Pneumococcal Vaccine Sales Forecast (2017-2022)
        12.2.5 Italy Pneumococcal Vaccine Sales Forecast (2017-2022)
    12.3 Pneumococcal Vaccine Market Forecast by Type (2017-2022)
    12.4 Pneumococcal Vaccine Market Forecast by Application (2017-2022)
13 Pneumococcal Vaccine Manufacturing Cost Analysis
    13.1 Pneumococcal Vaccine Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Price Trend of Key Raw Materials
        13.1.3 Key Suppliers of Raw Materials
        13.1.4 Market Concentration Rate of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
        13.2.1 Raw Materials
        13.2.2 Labor Cost
        13.2.3 Manufacturing Expenses
    13.3 Manufacturing Process Analysis of Pneumococcal Vaccine
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
    14.1 Pneumococcal Vaccine Industrial Chain Analysis
    14.2 Upstream Raw Materials Sourcing
    14.3 Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers in 2015
    14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
    15.1 Sales Channel
        15.1.1 Direct Marketing
        15.1.2 Indirect Marketing
        15.1.3 Marketing Channel Future Trend
    15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
    17.1 Methodology
    17.2 Analyst Introduction
    17.3 Data Source